The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
58 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $29,750,372 in first-year total cost, median $454,500.
Most frequent study sections
- Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section[NPAS]10
- Special Emphasis Panel[ZRG1 BBBP-S (60)]9
- Special Emphasis Panel[ZRG1 PSE-B (02)]9
- Special Emphasis Panel[ZRG1 PSE-F (60)]7
- Special Emphasis Panel[ZRG1 BBBP-X (64)]5
Most frequent institutions
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI4
- UNIVERSITY OF GEORGIA4
- BROAD INSTITUTE, INC.3
- NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC3
- UNIV OF NORTH CAROLINA CHAPEL HILL3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | 1/3 Akili: Phenotypic and genetic characterization of ADHD in Kenya and South Africa1R01MH132968-01 | ROBINSON, ELISE B | BROAD INSTITUTE, INC., MA | $787,040 | ZRG1 |
| 2023 | 3/3 Akili: Phenotypic and genetic characterization of ADHD in Kenya and South Africa1R01MH132950-01 | DONALD, KIRSTY | UNIVERSITY OF CAPE TOWN | $539,996 | ZRG1 |
| 2023 | 2/3 Akili: Phenotypic and genetic characterization of ADHD in Kenya and South Africa1R01MH132965-01 | ALI, AMINA ABUBAKAR | AGA KHAN UNIVERSITY (KENYA) | $537,090 | ZRG1 |
| 2023 | 2/2 Large-scale, single-cell characterization of molecular and cellular networks of mood regulation circuitry in major depressive disorder1R56MH131818-01 | TURECKI, GUSTAVO | CENTRE DE RECHERCHE DE L'HOPITAL DOUGLAS, PQ | $505,191 | ZRG1 |
| 2023 | 1/2 Large-scale, single-cell characterization of molecular and cellular networks of mood regulation circuitry in major depressive disorder1R56MH131817-01 | GOES, FERNANDO SAMPAIOHYDE, THOMAS MICHAEL | LIEBER INSTITUTE, INC., MD | $501,468 | ZRG1 |
| 2022 | 1/4 Asian Bipolar Genetics Network (A-BIG-NET)1R01MH130675-01 | HUANG, HAILIANG | BROAD INSTITUTE, INC., MA | $1,788,327 | ZRG1 |
| 2022 | 2/3 Sequencing and Trans-Diagnostic Phenotyping of Severe Mental Illness in Diverse Populations1R01MH130662-01 | CHARNEY, ALEXANDER W | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $821,793 | ZRG1 |
| 2022 | 1/2: CO2 Reactivity as a Biomarker of Non-response to Exposure-based Therapy1R01MH125951-01A1 | MONFILS, MARIE H.SMITS, JASPERTELCH, MICHAEL J. | UNIVERSITY OF TEXAS AT AUSTIN, TX | $763,817 | ZRG1 |
| 2022 | 1/3 Sequencing and Trans-Diagnostic Phenotyping of Severe Mental Illness in Diverse Populations1R01MH130671-01 | SULLIVAN, PATRICK F | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $758,664 | ZRG1 |
| 2022 | 2/2-CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy1R01MH125949-01A1 | OTTO, MICHAEL W. | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $596,287 | ZRG1 |
| 2022 | 1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)1R01MH128690-01A1 | ESPINOZA, RANDALLNARR, KATHERINE L | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $585,901 | ZRG1 |
| 2022 | 2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)1R01MH128692-01A1 | ABBOTT, CHRISTOPHER C | UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM | $536,848 | ZRG1 |
| 2022 | 3/3 Sequencing and Trans-Diagnostic Phenotyping of Severe Mental Illness in Diverse Populations1R01MH130672-01 | ESCOTT-PRICE, VALENTINAO'DONOVAN, MICHAELOWEN, MICHAEL JOHNWALTERS, JAMES TYNAN RHYS | CARDIFF UNIVERSITY | $529,070 | ZRG1 |
| 2022 | 4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)1R01MH128691-01A1 | MCCLINTOCK, SHAWN M | UT SOUTHWESTERN MEDICAL CENTER, TX | $528,406 | ZRG1 |
| 2022 | 1/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder1R01MH129724-01 | BUXBAUM, JOSEPH D. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $449,796 | ZRG1 |
| 2022 | 3/4 The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder1R01MH129725-01 | ROEDER, KATHRYN M | CARNEGIE-MELLON UNIVERSITY, PA | $404,766 | ZRG1 |
| 2022 | 4/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder1R01MH129751-01 | SANDERS, STEPHAN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $396,874 | ZRG1 |
| 2022 | 2/4 The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder1R01MH129722-01 | DALY, MARK JOSEPH | BROAD INSTITUTE, INC., MA | $389,237 | ZRG1 |
| 2022 | 2/2 - Inflammation and Stress Response in Familial and Nonfamilial Youth Suicidal Behavior2R01MH108032-06A1 | MANN, JOSEPH JOHN | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $384,038 | NPAS |
| 2022 | 1/2 Inflammation and Stress Response in Familial and Nonfamilial Youth Suicidal Behavior2R01MH108039-06A1 | MELHEM, NADINE M. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $365,758 | NPAS |
| 2022 | 3/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)1R01MH128686-01A1 | SHELINE, YVETTE I | UNIVERSITY OF PENNSYLVANIA, PA | $354,921 | ZRG1 |
| 2022 | 4/4 Asian Bipolar Genetics Network (A-BIG-NET)1R01MH130674-01 | KUO, PO HSIU | NATIONAL TAIWAN UNIVERSITY | $347,926 | ZRG1 |
| 2022 | 3/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)1R01MH127158-01A1 | PEARLSON, GODFREY D | YALE UNIVERSITY, CT | $338,642 | ZRG1 |
| 2022 | 1/5 - Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)1R01MH127179-01A1 | TAMMINGA, CAROL A | UT SOUTHWESTERN MEDICAL CENTER, TX | $328,000 | ZRG1 |
| 2022 | 5/5 - Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)1R01MH127172-01A1 | CLEMENTZ, BRETT A | UNIVERSITY OF GEORGIA, GA | $302,000 | ZRG1 |
| 2022 | 2/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)1R01MH127162-01A1 | GERSHON, ELLIOT SKEEDY, SARAH K | UNIVERSITY OF CHICAGO, IL | $291,618 | ZRG1 |
| 2022 | 2/4 Asian Bipolar Genetics Network (A-BIG-NET)1R01MH130665-01 | KENDLER, KENNETH SEEDMAN | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $279,630 | ZRG1 |
| 2022 | Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)1R01MH127174-01A1 | KESHAVAN, MATCHERI S. | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $234,136 | ZRG1 |
| 2022 | 3/4 Asian Bipolar Genetics Network (A-BIG-NET)1R01MH130673-01 | ZANDI, PETER P. | JOHNS HOPKINS UNIVERSITY, MD | $204,688 | ZRG1 |
| 2021 | 2/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact1R01MH124851-01 | BOERGLUM, ANDERSDAVIS, LEA KFRANKE, BARBARAKOENEN, KARESTAN CNEALE, BENJAMIN MICHAEL | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,195,691 | ZRG1 |
| 2021 | 1/2 Rare Genetic Variation and Risk for Obsessive Compulsive Disorder1R01MH124679-01 | GRICE, DOROTHY E | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $740,190 | ZRG1 |
| 2021 | 1/2 Neurodevelopmental and clinical trajectories of youth at risk for bipolar I disorder1R01MH125886-01 | ALMEIDA, JORGE R CSTRAKOWSKI, STEPHEN M | UNIVERSITY OF TEXAS AT AUSTIN, TX | $731,135 | NPAS |
| 2021 | 1/7 PGC: Advancing Discovery and Impact1R01MH124871-01 | BULIK, CYNTHIA MSULLIVAN, PATRICK F | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $730,941 | ZRG1 |
| 2021 | 7/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact1R01DA054869-01 | AGRAWAL, ARPANAEDENBERG, HOWARD JGELERNTER, JOEL | WASHINGTON UNIVERSITY, MO | $701,664 | ZRG1 |
| 2021 | 2/2 Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD1R01MH121608-01A1 | FOA, EDNA B | UNIVERSITY OF PENNSYLVANIA, PA | $700,680 | NPAS |
| 2021 | 2/2-Neurodevelopmental and Clinical Trajectories of Youth at Risk for Bipolar Disorder1R01MH125867-01 | DELBELLO, MELISSA P | UNIVERSITY OF CINCINNATI, OH | $624,675 | NPAS |
| 2021 | 1/2 Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD1R01MH121597-01A1 | SIMPSON, HELEN BLAIR | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $564,694 | NPAS |
| 2021 | 5/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact1R01MH124873-01 | LEWIS, CATHRYNO'DONOVAN, MICHAEL | CARDIFF UNIVERSITY | $561,638 | ZRG1 |
| 2021 | 3/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact1R01MH124839-01 | ANDREASSEN, OLE AHUCKINS, LAURA MARIANNE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $464,729 | ZRG1 |
| 2021 | 4/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact1R01MH124847-01 | NIEVERGELT, CAROLINE MSEBAT, JONATHAN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $459,203 | ZRG1 |
| 2021 | 3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)1R01MH124802-01 | PEARLSON, GODFREY D | YALE UNIVERSITY, CT | $376,378 | ZRG1 |
| 2021 | 1/5 - Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)1R01MH124813-01 | TAMMINGA, CAROL A | UT SOUTHWESTERN MEDICAL CENTER, TX | $368,625 | ZRG1 |
| 2021 | 2/5-Clozapine Response and Biomarker Correlates in Low-IEA Biotype-11R01MH124804-01 | GERSHON, ELLIOT SKEEDY, SARAH K | UNIVERSITY OF CHICAGO, IL | $364,500 | ZRG1 |
| 2021 | 2/2 B-SNIP: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT) - Resubmission - 11R01MH124805-01A1 | GIBBONS, ROBERT D | UNIVERSITY OF CHICAGO, IL | $328,000 | NPAS |
| 2021 | 5/5: Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)1R01MH124803-01 | CLEMENTZ, BRETT A | UNIVERSITY OF GEORGIA, GA | $320,338 | ZRG1 |
| 2021 | 1/2: B-SNIP: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)1R01MH124806-01A1 | CLEMENTZ, BRETT A | UNIVERSITY OF GEORGIA, GA | $302,000 | NPAS |
| 2021 | 4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)1R01MH124807-01 | KESHAVAN, MATCHERI S. | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $275,140 | ZRG1 |
| 2021 | 6/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact1R01MH124875-01 | CORVIN, AIDEN PETER | TRINITY COLLEGE DUBLIN | $157,749 | ZRG1 |
| 2021 | 2/2 Rare Genetic Variation and Risk for Obsessive Compulsive Disorder1R01MH124675-01 | CROWLEY, JAMES JOSEPH | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $77,750 | ZRG1 |
| 2020 | 2/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)1R01MH123662-01 | TAYLOR, WARREN D | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $991,848 | NPAS |
| 2020 | 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)1R01MH123660-01 | RUTHERFORD, BRET R | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $823,733 | NPAS |
| 2020 | 1/5 CAPER: Computerized Assessment of ProdromE Risk1R01MH120090-01A1 | GOLD, JAMES M. | UNIVERSITY OF MARYLAND BALTIMORE, MD | $589,572 | ZRG1 |
| 2020 | 5/5 CAPER: Computerized Assessment of Psychosis Risk1R01MH120089-01A1 | CORLETT, PHILIPWOODS, SCOTT W | YALE UNIVERSITY, CT | $572,946 | ZRG1 |
| 2020 | 1/2 - Anomalous Motor System Physiology in ADHD: Biomarker Validation and Modeling Domains of Function2R01MH095014-06 | GILBERT, DONALD L | CINCINNATI CHILDRENS HOSP MED CTR, OH | $415,119 | DBD |
| 2020 | 4/5 CAPER: Computerized assessment of psychosis risk1R01MH120092-01A1 | STRAUSS, GREGORY P | UNIVERSITY OF GEORGIA, GA | $401,699 | ZRG1 |
| 2020 | 2/5 CAPER Computerized assessment of psychosis risk1R01MH120088-01A1 | MITTAL, VIJAY A | NORTHWESTERN UNIVERSITY, IL | $377,685 | ZRG1 |
| 2020 | 2/2 - Anomalous Motor System Physiology in ADHD: Biomarker Validation and Modeling Domains of Function2R01MH078160-11 | MOSTOFSKY, STEWART H | HUGO W. MOSER RES INST KENNEDY KRIEGER, MD | $363,122 | DBD |
| 2020 | CAPER: Computerized Assessment of Psychosis Risk1R01MH120091-01A1 | ELLMAN, LAUREN M | TEMPLE UNIV OF THE COMMONWEALTH, PA | $317,000 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.